"Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid). (Q40733824)

23 September 2017

title

"Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid). (English)

1 reference

23 September 2017

Robyn M Hyde

1

1 reference

23 September 2017

Robert W Buckheit

series ordinal

2

1 reference

23 September 2017

Arthur D Broom

series ordinal

3

1 reference

23 September 2017

publication date

1 January 2002

1 reference

Nucleosides, Nucleotides & Nucleic Acids

23 September 2017

published in

1 reference

23 September 2017

volume

21

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

45-54

1 reference

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Local Therapy for Cytomegalovirus Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Unusual Single-Stranded Polyribonucleotides as Potent Anti-HIV Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

Polyribonucleotides containing thiopurines: synthesis and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120006529

21 January 2018

Identifiers

DOI

10.1081/NCN-120006529

1 reference

23 September 2017

1 reference